Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nkarta
Biotech
Nkarta continues pivot to lupus by shelving lymphoma program
Nkarta’s pivot from oncology to autoimmune disease has continued with the biotech halting work on its CAR NK in lymphoma to focus on lupus.
James Waldron
Nov 8, 2024 8:55am
How to get cell therapies flying off-the-shelf
May 31, 2024 9:00am
Nkarta's blood cancer CAR stalls again, driving deprioritization
Mar 22, 2024 9:11am
Volatile day for CAR-T biotechs after FDA reveals safety review
Nov 28, 2023 4:35pm
Nkarta moves cell therapy into autoimmune trials, lays off staff
Oct 18, 2023 3:21am
Ex-Nkarta exec Nadir Mahmood to lead UCSF spinout Rezo
Sep 20, 2023 7:00am
